ZAKA VC logo

ZAKA VC

zaka.vc

VCMatch tracks ZAKA VC as an investor focused on Biotech, Healthtech, and AI/ML companies, Pre-Seed and Seed rounds, United States, Canada, and Europe markets, and $130k check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$130k

Stages

Pre-Seed, Seed

Focus Areas

Biotech, Healthtech, AI/ML

Geography

United States, Canada, and Europe

Investment Thesis

ZAKA VC positions itself as a founder-friendly, operationally-experienced investor that bridges North America and Europe. Originally founded as a family office in 2019, the firm transitioned to a VC fund structure in 2024 with a €15M fund. The team emphasizes practical support beyond capital, with partners who are experienced operators and serial entrepreneurs who understand firsthand how to build, run, and sell companies.

Is ZAKA VC right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

Investment Focus

Who should take a closer look

ZAKA VC is most relevant for founders raising Pre-Seed and Seed rounds in Biotech, Healthtech, AI/ML, and Hardware, especially across United States, Canada, and Europe, with public check-size signals around $130k.

Focus statement

ZAKA VC is a seed & pre-seed VC fund investing mainly in the US and Europe, specifically targeting startups in Biotech, Healthcare, and Industrial Tech verticals. The firm explicitly seeks entrepreneurs with global ambition and creates bridges between North American and European markets.

Value Add

  • Trans-Atlantic bridge: Dual offices in Silicon Valley and Europe (Prague, Bratislava, London) to connect North America with Europe
  • Operator-led team: Partners are serial entrepreneurs and operators, not just financial investors - 'We know firsthand how to build, run and sell companies'
  • Healthcare/Biotech specialization: Described as 'One of the best Healthcare & Life Sciences portfolios in continental Europe'
  • Founder-friendly approach: Multiple founder testimonials emphasize transparent communication, founder-centric perspective, and 'right touch' investor support
  • Active European investor: 'rapidly become one of the most active investors in Europe' with 86 portfolio companies and 1 unicorn

Stage And Sector Fit

Portfolio Highlights

DeepSeq.AI

Biotech

Zephyr Fusion

Deeptech Hardtech

Kangaroo Biomedical

Biotech

Cirrus Therapeutics

Biotech

Kano Therapeutics

Biotech

Mews

Enterprise Software

Verne Robotics

Ai Ml

Avelis Health

Healthcare

+ 65 more companies in their portfolio

Investment Team

9 Partners at ZAKA VC

See who leads investments in your sector and how to connect with them.

Get partner details

Upload your deck to see who's the best fit for your startup.

Get Started